| 4 | Statement of changes in beneficial owner... | Aligos Therapeutics, Inc. | Latham & Watkins Llp (filing Agent) /fa | 06/26/2025 | |
| 4 | Statement of changes in beneficial owner... | Preston Heather | Latham & Watkins Llp (filing Agent) /fa | 06/26/2025 | |
| 4 | Statement of changes in beneficial owner... | Aligos Therapeutics, Inc. | Latham & Watkins Llp (filing Agent) /fa | 08/09/2024 | |
| 3 | Initial statement of beneficial ownershi... | Aligos Therapeutics, Inc. | Latham & Watkins Llp (filing Agent) /fa | 08/09/2024 | |
| 3 | Initial statement of beneficial ownershi... | Preston Heather | Latham & Watkins Llp (filing Agent) /fa | 08/09/2024 | |
| 4 | Statement of changes in beneficial owner... | Preston Heather | Latham & Watkins Llp (filing Agent) /fa | 08/09/2024 | |
| 4 | Statement of changes in beneficial owner... | Fusion Pharmaceuticals Inc. | Donnelley Financial Solutions File16 /fa | 06/14/2023 | |
| 4 | Statement of changes in beneficial owner... | Preston Heather | Donnelley Financial Solutions File16 /fa | 06/14/2023 | |
| 4 | Statement of changes in beneficial owner... | Preston Heather | Donnelley Financial Solutions File16 /fa | 06/14/2023 | |
| 4 | Statement of changes in beneficial owner... | Akouos, Inc. | Toppan Merrill/fa | 12/02/2022 | |
| Load More |